Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Medtronic PLC (MDT) vs Atlassian Corporation PLC (TEAM) Price & Performance

Medtronic PLCTrade
Atlassian Corporation PLCTrade

Price performance (Past 24H)

Key statistics

Medtronic PLC vs Atlassian Corporation PLC — how do they compare? Medtronic PLC trades at $87.92 (market cap $112.24B), while Atlassian Corporation PLC trades at $204.18 (market cap $51.53B). The key difference: Medtronic PLC is far larger — about 2.2× Atlassian Corporation PLC's market cap, and Medtronic PLC pays a 3.28% dividend while Atlassian Corporation PLC pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and Atlassian Corporation PLC for 64 Days on average.

MDTTEAM
Market Cap
$112.24B$51.53B
Volume
105,663,2362,904,511
Sector
HealthTechnology
52-Week High
$105.35$203.57
52-Week Low
$73.75$57.15
Typical Hold Time
63 Days64 Days
Enterprise Value
$131.58B$51.52B
Dividend Yield
3.28%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Medtronic PLC

Medtronic (MDT) trades at $87.80, up 2.68% today, with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with a 13.93% net income margin and consistent dividend growth over 49 years. Revenue growth accelerated to $33.54B in 2025, and analyst consensus targets $97.80, implying 11% upside. Recent news highlights regulatory approvals for medical devices and a $4B MiniMed exchange offer.

MDT offers value with a 3.2% dividend yield and reasonable valuation (P/E 21.6), but faces headwinds from technical bearishness and rising debt. The stock's appeal hinges on execution of growth initiatives in cardiovascular and neuroscience segments, though competitive and macroeconomic risks persist.

Atlassian Corporation PLC

Atlassian (TEAM) trades at $195.67, up 0.87% with bullish technical signals and strong analyst support. The stock shows improving fundamentals with revenue growth from $2.8B in 2022 to $5.22B in 2025, though net margins remain negative. Recent earnings beats and AI-driven cloud adoption provide momentum, with the current price near resistance at $196.

Outlook remains positive given robust cloud growth and AI integration, but high valuations and persistent losses pose risks. Wall Street consensus is strongly bullish with 30 buy ratings and a $191.16 target, though the stock trades above this level. Key risks include execution challenges and competitive pressures in the enterprise software space.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MDT
53% Buy47% Sell
Avg holding period · 63 Days
TEAM
0% Buy100% Sell
Avg holding period · 64 Days

Top news

Latest headlines on both assets

About Medtronic PLC

One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.

Read more on MDT →

About Atlassian Corporation PLC

Atlassian produces software that helps teams work together more efficiently and effectively. The company provides project planning and management software, collaboration tools, and IT help desk solutions. The company operates in four segments: subscriptions (term licenses and cloud agreements), maintenance (annual maintenance contracts that provide support and periodic updates and are generally attached to perpetual license sales), perpetual license (upfront sale for indefinite usage of the software), and other (training, strategic consulting, and revenue from the Atlassian Marketplace app store). Atlassian was founded in 2002 and is headquartered in Sydney.

Read more on TEAM →